相似文献
1
: Infections, Animal Modeling, and Therapeutics.
Cells. 2023 Jan 3;12(1):199. doi: 10.3390/cells12010199.
2
Beyond antibiotics: Emerging antivirulence strategies to combat Pseudomonas aeruginosa in cystic fibrosis.
Microb Pathog. 2024 Aug;193:106730. doi: 10.1016/j.micpath.2024.106730. Epub 2024 Jun 6.
3
The Effects of Antibiotic Combination Treatments on Pseudomonas aeruginosa Tolerance Evolution and Coexistence with Stenotrophomonas maltophilia.
Microbiol Spectr. 2022 Dec 21;10(6):e0184222. doi: 10.1128/spectrum.01842-22. Epub 2022 Dec 1.
4
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies.
Biotechnol Adv. 2019 Jan-Feb;37(1):177-192. doi: 10.1016/j.biotechadv.2018.11.013. Epub 2018 Nov 27.
5
Prevalence of antibiotic resistance of Pseudomonas aeruginosa in cystic fibrosis infection: A systematic review and meta-analysis.
Microb Pathog. 2022 Apr;165:105461. doi: 10.1016/j.micpath.2022.105461. Epub 2022 Feb 28.
6
Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa.
Microbiol Spectr. 2022 Aug 31;10(4):e0081322. doi: 10.1128/spectrum.00813-22. Epub 2022 Jun 21.
7
Antibiotic Resistance in Pseudomonas.
Adv Exp Med Biol. 2022;1386:117-143. doi: 10.1007/978-3-031-08491-1_5.
8
Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
Health Technol Assess. 2021 Nov;25(65):1-128. doi: 10.3310/hta25650.
9
Scorpionfish BPI is highly active against multiple drug-resistant isolates from people with cystic fibrosis.
Elife. 2023 Jul 18;12:e86369. doi: 10.7554/eLife.86369.
10
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Cochrane Database Syst Rev. 2023 Jun 2;6(6):CD004197. doi: 10.1002/14651858.CD004197.pub6.
引用本文的文献
1
Conservation and divergence of ciprofloxacin persister survival mechanisms between Pseudomonas aeruginosa and Escherichia coli.
PLoS Genet. 2025 Sep 2;21(9):e1011840. doi: 10.1371/journal.pgen.1011840. eCollection 2025 Sep.
2
Phage Banzai: Genomic and Functional Analysis of Novel with Lytic Activity Against .
Viruses. 2025 Aug 6;17(8):1088. doi: 10.3390/v17081088.
3
Biocontrol of Phage Resistance in Infections: Insights into Directed Breaking of Spontaneous Evolutionary Selection in Phage Therapy.
Viruses. 2025 Aug 4;17(8):1080. doi: 10.3390/v17081080.
4
Anti-QS Strategies Against Infections.
Microorganisms. 2025 Aug 7;13(8):1838. doi: 10.3390/microorganisms13081838.
5
Fc-modification of anti-PcrV gene-encoded antibodies modulates complement-mediated killing of Pseudomonas aeruginosa.
Front Immunol. 2025 Jul 31;16:1618297. doi: 10.3389/fimmu.2025.1618297. eCollection 2025.
6
Coordination of virulence factors and lifestyle transition in Pseudomonas aeruginosa through single-cell analysis.
Commun Biol. 2025 Aug 16;8(1):1236. doi: 10.1038/s42003-025-08693-6.
7
Biochemical Characterization and Genome Analysis of Pseudomonas loganensis sp. nov., a Novel Endophytic Bacterium.
Microbiologyopen. 2025 Aug;14(4):e70051. doi: 10.1002/mbo3.70051.
8
Pseudomonas aeruginosa in dental unit waterlines: an emerging threat of virulence genes in healthcare-associated infections.
BMC Oral Health. 2025 Aug 11;25(1):1313. doi: 10.1186/s12903-025-06668-x.
9
Best Practices in the Development and Use of Experimental Models of Bacterial Pneumonia: An Official American Thoracic Society Workshop Report.
Am J Respir Cell Mol Biol. 2025 Aug;73(2):178-199. doi: 10.1165/rcmb.2025-0322ST.
10
Insights on pathoadaptation of sequential isolates to the urinary tract.
Microbiol Spectr. 2025 Sep 2;13(9):e0045625. doi: 10.1128/spectrum.00456-25. Epub 2025 Jul 29.
本文引用的文献
1
Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.
Clin Infect Dis. 2023 Jul 18. doi: 10.1093/cid/ciad428.
2
Cytotoxins: Mechanisms of Cytotoxicity and Impact on Inflammatory Responses.
Cells. 2023 Jan 3;12(1):195. doi: 10.3390/cells12010195.
3
Fluoroquinolone antibiotics: Occurrence, mode of action, resistance, environmental detection, and remediation - A comprehensive review.
Environ Pollut. 2022 Dec 15;315:120440. doi: 10.1016/j.envpol.2022.120440. Epub 2022 Oct 17.
4
Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance.
Pharmaceutics. 2022 Aug 22;14(8):1749. doi: 10.3390/pharmaceutics14081749.
5
Honey: An Advanced Antimicrobial and Wound Healing Biomaterial for Tissue Engineering Applications.
Pharmaceutics. 2022 Aug 10;14(8):1663. doi: 10.3390/pharmaceutics14081663.
6
: Recent Advances in Vaccine Development.
Vaccines (Basel). 2022 Jul 8;10(7):1100. doi: 10.3390/vaccines10071100.
7
Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection.
Nat Commun. 2022 Jul 22;13(1):4239. doi: 10.1038/s41467-022-31837-9.
8
Frequency, Etiology, Mortality, Cost, and Prevention of Respiratory Tract Infections-Prospective, One Center Study.
J Clin Med. 2022 Jun 29;11(13):3764. doi: 10.3390/jcm11133764.
9
Infections in Cancer Patients.
Pathogens. 2022 Jun 12;11(6):679. doi: 10.3390/pathogens11060679.
10
Pseudomonal Diabetic Foot Infections: Vive la Différence?
Mayo Clin Proc Innov Qual Outcomes. 2022 May 23;6(3):250-256. doi: 10.1016/j.mayocpiqo.2022.04.005. eCollection 2022 Jun.
Zotero 插件